Version 5.4
Bos taurus Gene: BT.93015
Summary
InnateDB Gene IDBG-632468.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.93015
Gene Name glycine N-acyltransferase-like protein 3
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000025535
Encoded Proteins
IDBP-684083
glycine N-acyltransferase-like protein 3
IDBP-684085
glycine N-acyltransferase-like protein 3
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000203972:
Gene Information
Type Protein coding
Genomic Location Chromosome 23:22011817-22024395
Strand Forward strand
Band
Transcripts
ENSBTAT00000035917 ENSBTAP00000035783
ENSBTAT00000066179 ENSBTAP00000055779
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0016747 transferase activity, transferring acyl groups other than amino-acyl groups
GO:0047961 glycine N-acyltransferase activity
Biological Process
GO:0008152 metabolic process
Cellular Component
GO:0005739 mitochondrion
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000203972
View Gene Order
ENSMUSG00000091043
View Gene Order
Cross-References
SwissProt
TrEMBL E1BI09
UniProt Splice Variant
Entrez Gene 787783
UniGene Bt.93015
RefSeq NM_001145061 XM_005223512
HUGO HGNC:21349
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02055211
GenPept
RNA Seq Atlas 787783

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca